Janux Therapeutics, Inc.

Ownership Transactions Reported by 24 Insiders

Symbol
JANX on Nasdaq
Industry
Pharmaceutical Preparations
Location
10955 Vista Sorrento Parkway, Suite 200, San Diego, CA

Insiders trading volume in the past year

Janux Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Ra Capital Management, L.P. Director, 10%+ Owner $482M +$119M +32.7% Oct 18, 2024
Avalon Ventures XI, L.P. 10%+ Owner $347M -$205M -37.2% Oct 16, 2024
Jay Lichter 10%+ Owner $294M -$82.3M -21.9% Sep 13, 2024
Tighe Reardon Acting Chief Financial Officer $227M -$45M -16.5% Jun 3, 2024
Bregua Corp 10%+ Owner $22M Jun 15, 2021
David Alan Campbell President and CEO, Director $16.2M -$4.79M -22.8% Dec 3, 2024
Sheila Gujrathi Director $6.21M Nov 5, 2024
Thomas DiRaimondo Chief Scientific Officer $4.63M -$232K -4.77% Sep 27, 2024
Vickie L. Capps Director $3.79M Nov 5, 2024
Orbimed Advisors Llc Director $1.36M Dec 29, 2021
Andrew Hollman Meyer Chief Business Officer $1.09M -$2.3M -67.9% Dec 19, 2024
Eric Dobmeier Director $341K Jul 19, 2024
Natasha Hernday Director $341K Jul 19, 2024
Alana B. McNulty Director $137K Jun 26, 2024
Winston Kung Director $137K Jun 26, 2024
Ronald W. Barrett Director $137K Jun 26, 2024
Jake Simson Director $137K Jun 26, 2024
Peter A. Thompson Director Jun 14, 2022
Charles M. Winter Chief Technical Officer Jan 2, 2024
Stefan Heller Director Jun 14, 2022
Byron Robinson Chief Strategy Officer Jan 2, 2024
Maria Dobek Vice President, Accounting Aug 8, 2024
Wayne Godfrey Chief Medical Officer Jan 3, 2023
Shahram Salek-Ardakani Chief Scientific Officer Jan 3, 2022

Recent Insider Transactions by Companies or Individuals for Janux Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.